home / stock / obln / obln news

OBLN News and Press, Obalon Therapeutics From 08/13/20

Stock Information
Company Name: Obalon Therapeutics
Stock Symbol: OBLN
Market: NASDAQ
Menu
OBLN OBLN Quote OBLN Short OBLN News OBLN Articles OBLN Message Board
Get OBLN Alerts

News, Short Squeeze, Breakout and More Instantly...
OBLN - Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it has executed a consultin...
OBLN - Obalon Therapeutics EPS misses by $0.24

Obalon Therapeutics (NASDAQ: OBLN ) : Q2 GAAP EPS of -$0.54 misses by $0.24 . More news on: Obalon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

OBLN - Obalon Announces Second Quarter 2020 Financial Results

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial ...

OBLN - EVC, IMRN, NES and SJT among midday movers

Gainers:  Broadway Financial (NASDAQ: BYFC ) +195% . More news on: Broadway Financial Corporation, Cohen & Company Inc., LM Funding America, Inc., Stocks on the move, , Read more ...

OBLN - Obalon's retail treatment centers to remain shut; delays shipments

Obalon Therapeutics (NASDAQ: OBLN ) provides business updates. More news on: Obalon Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

OBLN - BYSI, KRMD among premarket losers

BeyondSpring (NASDAQ: BYSI )  -20%  after pricing ordinary shares. More news on: BeyondSpring Inc., Obalon Therapeutics, Inc., Repro Med Systems, Inc., Stocks on the move, , Read more ...

OBLN - Obalon Therapeutics EPS misses by $0.17, beats on revenue

Obalon Therapeutics (NASDAQ: OBLN ): Q1 GAAP EPS of -$0.68 misses by $0.17 . More news on: Obalon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

OBLN - Obalon Announces First Quarter 2020 Financial Results and Business Update

SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the fi...

OBLN - Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment

SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN ), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-filled intragastric balloon...

OBLN - William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director

SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces tha...
Previous 10 Next 10